Please wait a minute...
Reviews in Cardiovascular Medicine  2018, Vol. 19 Issue (4): 123-127     DOI: 10.31083/j.rcm.2018.04.3187
Review Previous articles | Next articles
The Cardiovascular effects of chocolate
Jose P. Garcia1, Adrian Santana2, Diego Lugo Baruqui3, Nicholas Suraci4, *()
1 Florida Atlantic University Medical School, Boca Raton, Florida. 33431
2 Johns Hopkins University, Baltimore, Maryland. 21218
3 Department of Internal Medicine. Mount Sinai Medical Center, Miami Beach, Florida. 33140
4 Department of Anesthesiology. Mount Sinai Medical Center, Miami Beach, Florida. 33140
Download:  PDF(408KB)  ( 738 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
The antioxidants as polyphenols, especially flavanols present in cocoa, exert a favorable effect on endothelium vasodilation, modulate inflammatory markers, and decrease platelet aggregation, lipid oxidation and insulin resistance. Recent nutritional intervention trials and molecular studies demonstrate that consumption of cocoa, particularly rich in flavanols, is beneficial to promote cardiovascular health. This review describes the cardiovascular effects of chocolate.
Key words:  Chocolate      flavanols      cardiovascular      nitric oxide     
Published:  30 December 2018     
*Corresponding Author(s):  Nicholas Suraci, E-mail: nicholas.suraci@gmail.com   

Cite this article: 

Jose P. Garcia, Adrian Santana, Diego Lugo Baruqui, Nicholas Suraci. The Cardiovascular effects of chocolate. Reviews in Cardiovascular Medicine, 2018, 19(4): 123-127.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm.2018.04.3187     OR     https://rcm.imrpress.com/EN/Y2018/V19/I4/123

[1] Baba S, Osakabe N, Kato Y, et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. The American Journal of Clinical Nutrition. 2007;85:709-717.
[2] Conen D, Chiuve SE, Everett BM, et al. Caffeine consumption and incident atrial fibrillation in women. The American Journal of Clinical Nutrition. 2010;92:509-514.
[3] Dong JY, Iso H, Yamagishi K, et al. Japan Public Health Center- based Prospective Study Group. Chocolate consumption and risk of stroke among men and women: A large population-based, prospective cohort study. Atherosclerosis. 2017;260:8-12.
[4] Gong F, Yao S, Wan J, et al. Chocolate consumption and risk of heart failure: a meta-analysis of prospective studies. Nutrients. 2017;9:402.
[5] Gu L, House SE, Wu X, et al. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. Journal of Agricultural and Food Chemistry. 2006;54:4057-4061.
[6] Hammer A, Koppensteiner R, Steiner S, et al. Dark chocolate and vascular function in patients with peripheral artery disease: A randomized, controlled cross-over trial. Clin Hemorheol Microcirc. 2015;59:145-153.
[7] Khawaja O, Gaziano JM, Djoussé L. Chocolate and coronary heart sisease: systematic review. Current Atherosclerosis Reports. 2011;13:447-452.
[8] Khawaja O, Petrone AB, Kanjwal Y, et al. Chocolate Consumption and Risk of Atrial Fibrillation (From the Physicians’ Health Study). American Journal of Cardiology. 2015;116:563-566.
[9] Kwok CS, Boekholdt SM, Lentjes MA, et al. Habitual chocolate consumption and risk of cardiovascular disease among healthy men and women. Heart. 2015;101:1279-1287.
[10] Larsson SC, Åkesson A, Gigante B, et al. Chocolate consumption and risk of myocardial infarction: a prospective study and metaanalysis. Heart. 2016;102:1017-1022.
[11] Larsson SC, Drca N, Jensen-Urstad M, et al. Chocolate consumption and risk of atrial fibrillation. Two cohort studies and a metaanalysis. American Heart Journal. 2018;195:86-90.
[12] Loffredo L, Perri L, Catasca E, et al. Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease. Journal of the American Heart Association. 2014;3:1-9.
[13] Mostofsky E, Berg Johansen M, Tjønneland A, et al. Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study. Heart. 2017; 103:1163-1167.
[14] Mostofsky E, Levitan EB, Wolk A, et al. Chocolate intake and the incidence of heart failure. A population-based prospective study of middle-aged and elderly women. Circulation: Heart Failure. 2010;3:612-616.
[15] Noad RL, Rooney C, McCall D, et al. Beneficial effect of a polyphenol-rich diet on cardiovascular risk: a randomised control trial. Heart. 2016;102:1371-1379.
[16] Persson IA, Persson K, Hagg S, et al. Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers-a nutrigenomics perspective. Journal of Cardiovascular Pharmacology. 2011;57:44-50.
[17] Ried K, Fakler P, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database of Systematic Reviews. 2017;25:1-120.
[18] Rostami A, Khalili M, Haghighat N, et al. High-cocoa polyphenolrich chocolate improves blood pressure in patients with diabetes and hypertension. ARYA Atherosclerosis. 2015;11:21-29.
[19] Tokede OA, Gaziano JM, Djoussé L. Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. European Journal of Clinical Nutrition. 2011;65:879-886.
[20] Sarriá B, Martínez-López S, Sierra-Cinos JL, et al. Regular consumption of a cocoa product improves the cardiometabolic profile in healthy and moderately hypercholesterolaemic adults. British Journal of Nutrition. 2014;111:122-134.
[21] Steihaus D, Mostofsky E, Levitan E, Mittleman M. Chocolate intake and incidence of Heart Failure: Findings form the Cohort of Swedish Men. American Heart Journal.2017;183:18-23.
[22] Yuan S, Li X, Jin Y, et al. Chocolate consumption and risk of coronary heart disease, stroke, and diabetes: a meta-analysis of prospective studies. Nutrients. 2017;9:1-10.
[1] Michele Provenzano, Giuseppe Coppolino, Teresa Faga, Carlo Garofalo, Raffaele Serra, Michele Andreucci. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 209-220.
[2] Girish Singhania, Abutaleb A. Ejaz, Peter A. McCullough, Aaron Y. Kluger, Saravanan Balamuthusamy, Bhagwan Dass, Namrata Singhania, Adhish Agarwal. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 111-120.
[3] Shanna J. Hardin, Mahavir Singh, Wintana Eyob, Jack C. Molnar, Rubens P. Homme, Akash K. George, Suresh C. Tyagi. Diet-induced chronic syndrome, metabolically transformed trimethylamine-N-oxide, and the cardiovascular functions[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 121-128.
[4] Wenyan Jiang, Mei Wang. New insights into the immunomodulatory role of exosomes in cardiovascular disease[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 153-160.
[5] Rudaynah A. Alali. A short review of proprotein convertase subtilisin/kexin type 9 inhibitors[J]. Reviews in Cardiovascular Medicine, 2019, 20(1): 1-8.
[6] Jennifer G. Robinson, Karol E. Watson. Identifying Patients for Nonstatin Therapy[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 1-8.
[7] Janani Rangaswami, Sandeep Soman, Peter A. McCullough. Key updates in Cardio-Nephrology from 2018: springboard to a bright Future[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 113-116.
[8] Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[9] Peter A. McCullough, Aaron Y. Kluger, Kristen M. Tecson, Clay M. Barbin, Andy Y. Lee, Edgar V. Lerma, Zachary P. Rosol, Sivan L. Kluger, Janani Rangaswami. Inhibition of the Sodium–Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2[J]. Reviews in Cardiovascular Medicine, 2018, 19(2): 51-63.
[10] Alberto Palazzuoli, Helen Hashemi, Lauren C. Jameson, Peter A. McCullough. Hyperuricemia and Cardiovascular Disease[J]. Reviews in Cardiovascular Medicine, 2017, 18(4): 134-145.
[11] Akanksha Agrawal, Deepanshu Jain, Eyob L. Feyssa, Aman M. Amanullah. Utility of Dobutamine Stress Echocardiography in Cardiac Risk Stratification of Patients Undergoing Orthotopic Liver Transplantation[J]. Reviews in Cardiovascular Medicine, 2017, 18(4): 146-154.
[12] Claudio Ronco, Federico Ronco, Peter A. McCullough. A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine[J]. Reviews in Cardiovascular Medicine, 2017, 18(3): 93-99.
[13] Ankit B. Shah, Neil Coplan. Cardiovascular Effects of Altitude on Performance Athletes[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 49-56.
[14] Boback Ziaeian, John Dinkler, Karol Watson. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 125-130.
[15] Tariq Bhat, Adi Neuman, Mohmad Tantary, Hilal Bhat, Daniel Glass, William Mannino, Muhammad Akhtar, Alina Bhat, Sumaya Teli, James Lafferty. Inhaled Nitric Oxide in Acute Pulmonary Embolism: A Systematic Review[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 1-8.
No Suggested Reading articles found!